Displaying drugs 2051 - 2075 of 2778 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Olaparib | 434.4628 C24H23FN4O3 |  | A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. | Poly (ADP-ribose) polymerase (PARP) inhibitors |
| Dexamethasone acetate | 434.4977 C24H31FO6 |  | Commonly known as decadron, dexamethasone acetate is a glucocorticosteroid previously marketed in the USA for the treatment of inflammatory respiratory, allergic, autoimmune, and other conditions.[T797,L10695,L14348] Developed in 1957, dexamethasone is... | Anti-Inflammatory Agents |
| Flunisolide | 434.4977 C24H31FO6 |  | An inhaled corticosteroid used as a prophylactic therapy in the maintenance treatment of asthma. | Anti-Asthmatic Agents / Anti-Inflammatory Agents / Corticosteroids |
| Paramethasone acetate | 434.504 C24H31FO6 |  | Not Annotated | Fused-Ring Compounds / Pregnadienes / Pregnadienetriols / Pregnanes / Steroids / Steroids, Fluorinated |
| Flupentixol | 434.52 C23H25F3N2OS |  | A thioxanthene neuroleptic used to treat schizophrenia and depression. | Thioxanthene Derivatives |
| Ribociclib | 434.548 C23H30N8O |  | A kinase inhibitor used to treat HR+, HER2- advanced or metastatic breast cancer. | Cyclin-dependent kinase (CDK) inhibitors / Protein Kinase Inhibitors |
| Resmetirom | 435.22 C17H12Cl2N6O4 |  | A thyroid hormone receptor-beta agonist used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis in adults. | BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / BSEP/ABCB11 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (weak) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / OAT3/SLC22A8 Inhibitors / OATP1B1/SLCO1B1 Inhibitors / OATP1B1/SLCO1B1 Substrates / OATP1B3 inhibitors / OATP1B3 substrates / Pyrimidines / Pyrimidinones / Thyroid hormone receptor-beta (THR-beta) agonist / UGT1A4 Inhibitors / UGT1A9 Inhibitors |
| Etravirine | 435.277 C20H15BrN6O |  | A non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV-1 infections in combination with other antiretroviral agents. | Non-Nucleoside Reverse Transcriptase Inhibitors |
| Aztreonam | 435.433 C13H17N5O8S2 |  | A beta-lactam antibiotic used to treat select aztreonam sensitive gram negative bacteria. | Anti-Bacterial Agents / Monobactam Antibacterial / Monobactams |
| Valsartan | 435.5188 C24H29N5O3 |  | An angiotensin-receptor blocker used to manage hypertension alone or in combination with other antihypertensive agents and to manage heart failure in patients who are intolerant to ACE inhibitors. | Angiotensin II Antagonists and Calcium Channel Blockers / Angiotensin II Antagonists and Diuretics / Angiotensin II receptor blockers (ARBs) and calcium channel blockers / Angiotensin II receptor blockers (ARBs) and diuretics |
| Rivaroxaban | 435.881 C19H18ClN3O5S |  | A factor Xa inhibitor used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). May also be used as thrombosis prophylaxis in specific situations. | Direct factor Xa inhibitors / Factor Xa Inhibitors / Morpholines / Thiophenes |
| Cloxacillin | 435.881 C19H18ClN3O5S |  | An antibiotic agent used for the treatment of beta-hemolytic streptococcal and pneumococcal infections as well as staphylococcal infections. | Beta-Lactamase Resistant Penicillins |
| Laropiprant | 435.89 C21H19ClFNO4S |  | Laropiprant is an ingredient in the EMA-withdrawn product Pelzont. | Heterocyclic Compounds, Fused-Ring |
| Zoledronate D,L-Lysine Monohydrate | 436.295 C11H26N4O10P2 |  | Not Annotated | Not Annotated |
| Flurandrenolide | 436.5136 C24H33FO6 |  | A corticosteroid used to treat corticosteroid-responsive dermatoses. | Corticosteroids, Potent (Group III) |
| Ertugliflozin | 436.89 C22H25ClO7 |  | An SGLT2 inhibitor used to treat type 2 diabetes mellitus alone or in combination with other antidiabetic drugs. | Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Sodium-Glucose Transporter 2 Inhibitors |
| Picosulfuric acid | 437.44 C18H15NO8S2 |  | A stimulant laxative used for cleansing of the colon as a preparation for colonoscopy in adults. | Laxatives |
| Isavuconazole | 437.47 C22H17F2N5OS |  | Indicated for patients 18 years of age and older for the treatment of invasive aspergillosis [FDA Label]. Indicated for patients 18 years of age and older for the treatment of... | Triazole and tetrazole derivatives / Triazole Derivatives |
| Pazopanib | 437.518 C21H23N7O2S |  | An antineoplastic agent used in the treatment of advanced renal cell cancer and advanced soft tissue sarcoma in patients with prior chemotherapy. | Protein Kinase Inhibitors |
| Fluphenazine | 437.522 C22H26F3N3OS |  | A phenothiazine used to treat patients requiring long-term neuroleptic therapy. | Phenothiazines With Piperazine Structure |
| Sertaconazole | 437.77 C20H15Cl3N2OS |  | A topical antifungal agent used in the treatment of interdigital tinea pedis in immunocompetent patients. | Imidazole and Triazole Derivatives / Imidazole Derivatives |
| Quinapril | 438.5161 C25H30N2O5 |  | An ACE inhibitor prodrug used to treat hypertension, congestive heart failure, and slow rate of progression of renal disease. | ACE Inhibitors and Diuretics |
| Remimazolam | 439.313 C21H19BrN4O2 |  | An ultra short-acting benzodiazepine used for the induction and maintenence of procedural sedation during short procedures. | Benzodiazepines and benzodiazepine derivatives |
| Pivmecillinam | 439.569 C21H33N3O5S |  | A prodrug of the beta lactam antibiotic mecillinam, indicated for the treatment of uncomplicated urinary tract infections (UTIs). | Penicillins With Extended Spectrum |
| Polythiazide | 439.882 C11H13ClF3N3O4S3 |  | A thiazide diuretic used in the management of hypertension and treatment of edema. | Sulfonamides |
Displaying drugs 2051 - 2075 of 2778 in total